We are live on ! Find out more
FT

Fiduciary Trust Portfolio holdings

AUM $8.46B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
-1.09%
1 Year Est. Return
+21.38%
3 Year Est. Return
+65.44%
5 Year Est. Return
+79.3%
10 Year Est. Return
+269.63%
AUM
$5.62B
AUM Growth
+$453M
Cap. Flow
+$571M
Cap. Flow %
10.16%
Top 10 Hldgs %
41.52%
Holding
659
New
24
Increased
161
Reduced
323
Closed
13

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$467M
2
MRNA icon
Moderna
MRNA
+$100M
3
IEUR icon
iShares Core MSCI Europe ETF
IEUR
+$37.9M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
+$13M
5
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$11M

Top Sells

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$13.8M
2
AAPL icon
Apple
AAPL
+$8.04M
3
MSFT icon
Microsoft
MSFT
+$5.65M
4
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$4.68M
5
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$3.06M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.47%
2 Technology 15.31%
3 Healthcare 11.09%
4 Financials 6.35%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SABR icon
626
Sabre
SABR
$716M
$204K ﹤0.01%
17,250
-400
-2% -$4.54K
BKI
627
DELISTED
Black Knight, Inc. Common Stock
BKI
$203K ﹤0.01%
+2,818
New +$217K
KMI icon
628
Kinder Morgan
KMI
$70.9B
$202K ﹤0.01%
12,059
– –
VGLT icon
629
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
$201K ﹤0.01%
2,295
-126
-5% -$11.4K
NRIX icon
630
Nurix Therapeutics
NRIX
$2.45B
$200K ﹤0.01%
+6,680
New +$206K
NUV icon
631
Nuveen Municipal Value Fund
NUV
$1.91B
$184K ﹤0.01%
16,233
– –
JBLU icon
632
JetBlue
JBLU
$2.13B
$180K ﹤0.01%
+11,762
New +$180K
LOGC
633
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$174K ﹤0.01%
37,998
– –
NOK icon
634
Nokia
NOK
$46.9B
$160K ﹤0.01%
29,449
– –
FHTX icon
635
Foghorn Therapeutics
FHTX
$278M
$152K ﹤0.01%
10,879
– –
F icon
636
Ford
F
$60.9B
$143K ﹤0.01%
10,065
-3
-0% -$41
JNCE
637
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$132K ﹤0.01%
17,722
+4,492
+34% +$27.8K
AGTC
638
DELISTED
Applied Genetic Technologies Corporation
AGTC
$120K ﹤0.01%
40,000
– –
MVIS icon
639
Microvision
MVIS
$84.8M
$111K ﹤0.01%
+10,000
New +$139K
TEF
640
DELISTED
Telefonica
TEF
$79K ﹤0.01%
18,004
+15
+0.1% +$67
UEC icon
641
Uranium Energy
UEC
$4.47B
$50K ﹤0.01%
16,470
– –
UROY
642
Uranium Royalty Corp
UROY
$478M
$48K ﹤0.01%
13,370
– –
VVR icon
643
Invesco Senior Income Trust
VVR
$456M
$47K ﹤0.01%
10,564
-724
-6% -$3.15K
SREV
644
DELISTED
ServiceSource International, Inc.
SREV
$45K ﹤0.01%
33,403
– –
CARM
645
DELISTED
Carisma Therapeutics
CARM
$16K ﹤0.01%
1,035
– –
MOTS
646
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$16K ﹤0.01%
+77
New +$19.4K
ATR icon
647
AptarGroup
ATR
$8.69B
– –
-1,605
Closed -$226K
BUD icon
648
AB InBev
BUD
$164B
– –
-3,337
Closed -$240K
BURL icon
649
Burlington
BURL
$23.4B
– –
-672
Closed -$216K
CP icon
650
Canadian Pacific Kansas City
CP
$81B
– –
-2,910
Closed -$224K
23 24 25
26
27

Similar funds

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Fiduciary Trust's Q3 2021 Portfolio in Review

As of Q3 2021, Fiduciary Trust held 659 positions worth $5.62B, up 8.8% from $5.17B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fiduciary Trust deployed $571M of net new capital in Q3 2021, opening 24 new positions and adding to 161 existing holdings. Its largest new stake was Coupang: 13,522,840 shares worth $377M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 9.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $13.8M trimmed.

  • Fiduciary Trust's largest Q3 2021 buy was Coupang: 13,522,840 shares worth $377M.
  • Fiduciary Trust added most to Moderna in Q3 2021, an estimated $100M increase.
  • Fiduciary Trust's biggest Q3 2021 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $13.8M.
  • Fiduciary Trust fully exited Invesco MSCI Sustainable Future ETF in Q3 2021, selling an estimated $491K.
  • Fiduciary Trust's ten largest holdings make up 42% of its $5.62B portfolio in Q3 2021.
  • Fiduciary Trust opened 24 new positions and closed 13 in Q3 2021.
  • Fiduciary Trust's portfolio value rose 8.8% quarter-over-quarter to $5.62B.

Based on Fiduciary Trust's 13F filing for Q3 2021, filed 12 Nov 2021.